Genmab Fair Value
0M
The fair market value of 0MGB.L stock is 2955.32 DKK. Relative to the market price of 1555.5 DKK Genmab is undervalued by 90%
Eyestock's quantitative valuation approach is based on the method of estimating historical multipliers. To determine whether a stock is undervalued, we compare its current price to our estimated of fair value. The more undervalued a stock is, the more investment is profitable.
Fair Relative Value
Genmab Valuation
Current 0MGB.L share ticker price is 1555.5 DKK.
The fair value level of 2955.32 DKK can be considered as an effective entry point for long-term investors to start investing in 0MGB.L stock. For a more in-depth assessment, we provide a minimum value that can be used to increase a stock position and a maximum one that can be used to reduce it.
Price chart is not available
Current market price
Current price is 90% lower its fair value
Current price is 36% lower its minimum value
Current price is 230% lower its maximum value
Market price:
0MGB.L stock is greatly undervalued
It means the current price may concern as a Low Risk Entry Point
Genmab A/S Stock Valuation Calculator
How do we value a stock?
As fair value, we use the product of the median Price-to-earnings ratios at the end of each reporting period for the last 5 years and earnings per share for the last 12 months. By analogy with the fair value, we calculate the maximum and minimum ones using the corresponding P/E extremums.
1
Maximum P/E over 5 years
61.68
2
Median P/E over 5 years
35.5
3
Minimum P/E over 5 years
25.45
4
Earning per share (last 12 months)
83.24 DKK
Maximum value
1
x
4
=
5 134.32 DKK
Fair value
2
x
4
=
2 955.32 DKK
Minimum value
3
x
4
=
2 118.5 DKK
Genmab A/S price metrics
1.15
Annual return (geometric mean)
31.88
Risk (standard deviation) of returns
β
0.05
Beta (volatility compared to market)